DR. JACK S REMINGTON, M.D.
Osteopathic Medicine in Palo Alto, CA
License number
California A17789
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2
795 El Camino Real Palo Alto Medical Foundation, Palo Alto, CA 94301
1995 Valparaiso Ave, Menlo Park, CA 94025
1995 Valparaiso Ave, Menlo Park, CA 94025
Phone
(650) 853-6061
(650) 329-9853 (Fax)
(650) 326-3102
(650) 329-9853 (Fax)
(650) 326-3102
Organization information
See more information about JACK S REMINGTON at bizstanding.comSurgecenter Of Palo Alto - Grace W Chan MD
795 El Camino Real, Palo Alto, CA 94301
Doing business as:
Surgecenter Of Palo Alto - Haleh Agdassi MD<br>Surgecenter Of Palo Alto - Jeffery M Gregori DPM<br>Surgecenter Of Palo Alto - Janet Marie Volpe MD<br>Surgecenter Of Palo Alto - James Stringer MD<br>Surgecenter Of Palo Alto - Jack S Remington MD<br>Surgecenter Of Palo Alto - Jennifer S Falk MD<br>Surgecenter Of Palo Alto - Irena L Ilic MD<br>Surgecenter Of Palo Alto - Ellen M Schneider MD<br>Surgecenter Of Palo Alto - Jason W Much MD<br>Surgecenter Of Palo Alto - Emilie H Osborn MD<br>Surgecenter Of Palo Alto - Frederick A Lloyd MD<br>Surgecenter Of Palo Alto - Ian T Kroes MD<br>Surgecenter Of Palo Alto - Hou Leong Od<br>Surgecenter Of Palo Alto - Jeffrey W Walton MD<br>Surgecenter Of Palo Alto - Heather A Harris MD
Phone:
(650) 321-4121 (Phone), (650) 330-4520 (Fax), (650) 853-4765 (Fax)
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Sports Medicine Physicians & Surgeons, ...
Professional information
Jack S Remington, Palo Alto CA
Specialties:
Internist
Address:
795 El Camino Real, Palo Alto, CA 94301
Education:
University of Illinois, College of Medicine - Doctor of Medicine
UCSF Medical Center - Residency - Family Medicine
UCSF Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Jack S Remington, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 329-9853 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (510) 208-1776 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 853-2966 (Fax)
(650) 321-4121 (Phone), (650) 329-9853 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (510) 208-1776 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 853-2966 (Fax)
Certifications:
Internal Medicine, 1965
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
795 El Camino Real, Palo Alto 94301
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Univ Of Il Coll Of Med
Graduated: 1956
U Calif Ser-San Francisco C
U C S F Medical Center
NIAID-NIH/Harvard-Thorndike
Univ Of Il Coll Of Med
Graduated: 1956
U Calif Ser-San Francisco C
U C S F Medical Center
NIAID-NIH/Harvard-Thorndike
Treatment For Toxoplasmosis With A Composition Comprising A Folate Antagonist And A Spiropiperidyl Derivative Of Rifamycin S
US Patent:
5670496, Sep 23, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/476508
Inventors:
Jack S. Remington - Menlo Park CA
Fausto G. Araujo - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Assignee:
Palo Alto Medical Foundation - Palo Alto CA
International Classification:
A61K 3133, A61K 31505
US Classification:
514183
Abstract:
A method of reducing the severity of toxoplasmosis resulting from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Treatment For Toxoplasmoisis With A Composition Containing A Hydroxynaphthoquinone And A Spiropiperidyl Derivative Of Rifamycin S.
US Patent:
5641769, Jun 24, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/481689
Inventors:
Jack S. Remington - Menlo Park CA
Fausto G. Araujo - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Assignee:
Palo Alto Medical Foundation - Palo Alto CA
International Classification:
A61K 3133, A61K 3112
US Classification:
514183
Abstract:
A method of reducing the severity of toxoplasmosis resulting from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ting system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Treatment For Toxoplasmosis With A Composition Comprising A Macrolide Antibiotic And A Spiropiperidyl Derivative Of Rifamycin S
US Patent:
5648345, Jul 15, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/474998
Inventors:
Jack S. Remington - Menlo Park CA
Fausto G. Araujo - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Assignee:
Palo Alto Medical Foundation - Palo Alto CA
International Classification:
A61K 3133, A61K 3155
US Classification:
514183
Abstract:
A method of reducing the severity of toxoplasmosis resulring from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Treatment For Toxoplasmosis With A Composition Comprising A Sulfonamide And A Spiropiperidyl Derivative Of Rifamycin S.
US Patent:
5650405, Jul 22, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/481741
Inventors:
Jack S. Remington - Menlo Park CA
Fausto G. Araujo - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Assignee:
Palo Alto Medical Foundation - Palo Alto CA
International Classification:
A61K 3133, A61K 31505, A61K 31425, A61K 3142
US Classification:
514183
Abstract:
A method of reducing the severity of toxoplasmosis resulting from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Nucleotide Sequence Encoding The Toxoplasma Gondii P22 Gene
US Patent:
5215917, Jun 1, 1993
Filed:
Nov 3, 1989
Appl. No.:
7/431669
Inventors:
Fausto G. De Araujo - Palo Alto CA
Jeffrey B. Prince - Mountain View CA
Jack S. Remington - Menlo Park CA
Jeffrey B. Prince - Mountain View CA
Jack S. Remington - Menlo Park CA
Assignee:
Research Institute of Palo Alto Medical Foundation - Palo Alto CA
International Classification:
C12P 2102, C12P 1934, C12N 1500, C12N 700, C12N 121, C12N 116, C12N 118, C07K 300, C07H 1512
US Classification:
43525233
Abstract:
Genetic material encoding the P22 peptide of Toxoplasma gondii has been isolated and characterized. This genetic material allows the production of peptides for use in diagnosis or immunization or can itself be directly used in hybridization assays.
Treatment For Toxoplasmosis
US Patent:
5529994, Jun 25, 1996
Filed:
Feb 28, 1994
Appl. No.:
8/203539
Inventors:
Jack S. Remington - Menlo Park CA
Fausto G. Araujo - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Assignee:
Palo Alto Medical Foundation - Palo Alto CA
International Classification:
A61K 3133, A61K 3170
US Classification:
514183
Abstract:
A method of reducing the severity of toxoplasmosis resulting from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Sandwich Immunoassay And Compositions For Use Therein
US Patent:
4361647, Nov 30, 1982
Filed:
May 22, 1980
Appl. No.:
6/152328
Inventors:
Jack S. Remington - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Fausto G. Araujo - Palo Alto CA
Assignee:
Palo Alto Medical Research Foundation - Palo Alto CA
International Classification:
C12Q 166
US Classification:
435 7
Abstract:
An improved sandwich immunoassay for Toxoplasma gondii antigens associated with acute forms of Toxoplasma infection is disclosed. The assay employs either an F(ab'). sub. 2 fragment of IgG which reacts specifically with such antigens or a monoclonal antibody for such antigens as the substrate layer in the sandwich. The assay is sensitive and, unlike prior sandwich assays for the antigen, is not affected significantly by cross-reactions with rheumatoid factor.
Azithromycin And Derivatives As Antiprotozoal Agents
US Patent:
4963531, Oct 16, 1990
Filed:
Aug 16, 1988
Appl. No.:
7/359676
Inventors:
Jack S. Remington - Menlo Park CA
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 3170, A61K 3171
US Classification:
514 29
Abstract:
A method of use of azithromycin or derivatives of azithromycin in the treatment of infection caused by Toxoplasma gondii in mammals is disclosed.